Treatment Approaches for Adolescent Cannabis Use Disorder
Adolescent cannabis use disorder treatment is critical due to increased psychiatric risks associated with cannabis use in teens. Early intervention can help mitigate the development of psychotic, bipolar, depressive, and anxiety disorders. Clinicians…
Insights into Cannabis-Induced Psychosis and Schizophrenia Progression
Cannabis-induced psychosis schizophrenia progression insights reveal that a significant portion of patients develop schizophrenia spectrum disorders over time. This progression underscores the need for careful clinical monitoring. Understanding these…
Cannabis and Mental Health: It’s Not Just About ‘Cannabis’
Cannabis mental health risk limited benefits are increasingly recognized as dependent on cannabinoid type, dose, and individual factors. This 2025 review highlights the distinct roles of THC and CBD in psychiatric outcomes. Understanding these nuances is…
Cannabinoid Clinical Trials: GLP-1 Receptors and Mental Health
The GLP-1 receptor agonists mental health study reveals potential protective effects against schizophrenia and other psychiatric conditions. This Mendelian randomization analysis uses genetic proxies to explore causal relationships. Findings suggest…
Understanding the Risk of Psychiatric Disorders from Adolescent Cannabis Use
Adolescent cannabis psychiatric disorders risk includes increased chances of psychotic, bipolar, depressive, and anxiety disorders. This risk is supported by large population-level clinical data. Understanding this risk helps guide adolescent mental…